These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 783198)

  • 21. Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide.
    Lecomte MJ; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1977 Dec; 3(4):239-43. PubMed ID: 340296
    [No Abstract]   [Full Text] [Related]  

  • 22. Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.
    Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1122-8. PubMed ID: 2952663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of pancreatic alpha cell function in normal and diabetic subjects.
    Unger RH; Aguilar-Parada E; Müller WA; Eisentraut AM
    J Clin Invest; 1970 Apr; 49(4):837-48. PubMed ID: 4986215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of an artificial beta cell in surgery.
    Horwitz DL; Schwartz SS
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.
    Wahid M; Naveed AK; Hussain I
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):11-4. PubMed ID: 16441980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon secretion in subjects with prediabetes, diabetes mellitus and obesity.
    Slavnov VN; Epshtein EV; Efimov AS; Malinkovich VD; Stepanenko LI
    Endocrinologie; 1979; 17(3):213-8. PubMed ID: 504963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.
    Abdul-Ghani M; DeFronzo RA
    J Clin Endocrinol Metab; 2007 May; 92(5):1778-84. PubMed ID: 17327375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus.
    Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S
    J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of prostaglandin E1 and prostaglandin F2alpha on insulin and glucagon plasma levels during the intravenous glucose tolerance test in man.
    Giugliano D; Torella R; Improta L; D'Onofrio F
    Diabete Metab; 1978 Sep; 4(3):187-91. PubMed ID: 710679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic effects of somatostatin in maturity-onset diabetes.
    Tamborlane WV; Sherwin RS; Hendler R; Felig P
    N Engl J Med; 1977 Jul; 297(4):181-3. PubMed ID: 876274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic alpha and beta cell function in familial dysbetalipoproteinemia.
    Tan MH; Havel RJ; Gerich JE; Soeldner JS; Kane JP
    Horm Metab Res; 1980 Sep; 12(9):421-5. PubMed ID: 7000652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects.
    Pfeifer MA; Beard JC; Halter JB; Judzewitsch R; Best JD; Porte D
    J Clin Endocrinol Metab; 1983 Mar; 56(3):586-91. PubMed ID: 6337181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of endogenous glucagon release on hyperglycemic responses to catecholamines in normal fed and diabetic rats.
    Woodson LC; Potter DE
    J Pharmacol Exp Ther; 1979 Sep; 210(3):458-64. PubMed ID: 480194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon and diabetes mellitus.
    Reach G; Assan R
    Diabete Metab; 1979 Mar; 5(1):63-70. PubMed ID: 376365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese diabetics].
    Cucinotta D; Quartarone M; Saitta A; Sardo A; Squadrito G
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2290-6. PubMed ID: 754729
    [No Abstract]   [Full Text] [Related]  

  • 37. Ketoacidosis in pancreatectomized man.
    Barnes AJ; Bloom SR; Goerge K; Alberti GM; Smythe P; Alford FP; Chisholm DJ
    N Engl J Med; 1977 Jun; 296(22):1250-3. PubMed ID: 404553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy.
    Rizza RA; Gerich JE; Haymond MW; Westland RE; Hall LD; Clemens AH; Service FJ
    N Engl J Med; 1980 Dec; 303(23):1313-8. PubMed ID: 7001229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressive effect of vasopressin on ketosis in diabetic rats.
    Harano A; Hidaka H; Kojima H; Harano Y; Shigeta Y
    Horm Metab Res; 1992 Jan; 24(1):5-9. PubMed ID: 1612560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion.
    Gerich JE; Lorenzi M; Tsalikian E; Karam JH
    Diabetes; 1976 Jan; 25(1):65-71. PubMed ID: 1107095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.